Support for funding the Consortium of Food Allergy Research at the NIAID.
Support funding for food allergy research.
H.R. 2474, the Strengthening Medicare for Patients and Providers Act
H.R. 6371, the Provider Reimbursement Stability Act of 2023
Legislation affecting the Medicare Physician Fee Schedule.
COVID-19 PHE Waivers
Issues concerning physician participation in MIPS and Alternative Payment Models.
Expanding Medicare coverage for telehealth.
Medicare prescription drug prices
Network Adequacy for Health Plans
Prior authorization in Medicare Advantage plans
American Rescue Plan implementation
No Surprises Act Implementation
Proposals to reform prescription drug pricing
COVID-19 PHE Waivers
Heat and Smoke-Related Air Quality Impact on Health
Specialty Physicians Advancing Rural Care (SPARC) Act
Healthcare Workforce Issues
Healthy at Home Act
Lower Costs, More Transparency Act
Bipartisan Primary Care and Health Workforce Act
PBM Reforms
Inhaler price and access issues
H.R.6487/S.3805, the No Fees for EFTs Act
Cybersecurity issues related to the cyberattack on Change Healthcare
Financial relief for medical practices due to the Change Healthcare cyberattack
H.R.6965 - EPIPEN Act
FAA Reauthorization Legislation
Making epinephrine for anaphylaxis available on airplanes
FAA Reviews of Airline Emergency Medical Kit Content List
Duration: November 1, 2007
to
present
General Issues: Budget/Appropriations , Medicare/Medicaid , Health Issues , Transportation , Medical/Disease Research/Clinical Labs
Spending: about $2,020,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2007: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Natl Economic Council (NEC), Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Y
Y
Department of Health and Human Services, Y
Y
Department of Health and Human Services., Y
Y
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $40,000. The report was filed on April 19.
Original Filing: 301566225.xml
Lobbying Issues
Support for funding the Consortium of Food Allergy Research at the NIAID.
Support funding for food allergy research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 2474, the Strengthening Medicare for Patients and Providers Act
H.R. 6371, the Provider Reimbursement Stability Act of 2023
Legislation affecting the Medicare Physician Fee Schedule.
COVID-19 PHE Waivers
Issues concerning physician participation in MIPS and Alternative Payment Models.
Expanding Medicare coverage for telehealth.
Medicare prescription drug prices
Network Adequacy for Health Plans
Prior authorization in Medicare Advantage plans
Agencies Lobbied
U.S. Senate
Lobbying Issues
American Rescue Plan implementation
No Surprises Act Implementation
Proposals to reform prescription drug pricing
COVID-19 PHE Waivers
Heat and Smoke-Related Air Quality Impact on Health
Specialty Physicians Advancing Rural Care (SPARC) Act
Healthcare Workforce Issues
Healthy at Home Act
Lower Costs, More Transparency Act
Bipartisan Primary Care and Health Workforce Act
PBM Reforms
Inhaler price and access issues
H.R.6487/S.3805, the No Fees for EFTs Act
Cybersecurity issues related to the cyberattack on Change Healthcare
Financial relief for medical practices due to the Change Healthcare cyberattack
H.R.6965 - EPIPEN Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
FAA Reauthorization Legislation
Making epinephrine for anaphylaxis available on airplanes
FAA Reviews of Airline Emergency Medical Kit Content List
Agencies Lobbied
U.S. Senate
4th Quarter, 2023
In Q4, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $40,000. The report was filed on Jan. 19.
Original Filing: 301530898.xml
Lobbying Issues
Appropriations for Children's Asthma Treatment Grants Program.
Support for funding the Consortium of Food Allergy Research at the NIAID.
Support funding for food allergy research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 2474
Legislation affecting the Medicare Physician Fee Schedule.
COVID-19 PHE Waivers
Issues concerning physician participation in MIPS and Alternative Payment Models.
Expanding Medicare coverage for telehealth.
Medicare prescription drug prices
Network Adequacy for Health Plans
Prior authorization in Medicare Advantage plans
Agencies Lobbied
U.S. Senate
Lobbying Issues
American Rescue Plan implementation
No Surprises Act Implementation
Proposals to reform prescription drug pricing
COVID-19 PHE Waivers
Heat and Smoke-Related Air Quality Impact on Health
Specialty Physicians Advancing Rural Care (SPARC) Act
Healthcare Workforce Issues
Healthy at Home Act
Lower Costs, More Transparency Act
Bipartisan Primary Care and Health Workforce Act
PBM Reforms
Inhaler price and access issues
Agencies Lobbied
U.S. Senate
Lobbying Issues
FAA Reauthorization Legislation
Making epinephrine for anaphylaxis available on airplanes
FAA Reviews of Airline Emergency Medical Kit Content List
Agencies Lobbied
U.S. Senate
3rd Quarter, 2023
In Q3, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $40,000. The report was filed on Oct. 20, 2023.
Original Filing: 301510309.xml
Lobbying Issues
Appropriations for Children's Asthma Treatment Grants Program.
Support for funding the Consortium of Food Allergy Research at the NIAID.
Support funding for food allergy research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 2474
Legislation affecting the Medicare Physician Fee Schedule.
COVID-19 PHE Waivers
Issues concerning physician participation in MIPS and Alternative Payment Models.
Expanding Medicare coverage for telehealth.
Medicare prescription drug prices
Network Adequacy for Health Plans
Prior authorization in Medicare Advantage plans
PBM Issues
Agencies Lobbied
U.S. Senate
Lobbying Issues
American Rescue Plan implementation
No Surprises Act Implementation
Proposals to reform prescription drug pricing
COVID-19 PHE Waivers
Heat and Smoke-Related Air Quality Impact on Health
Specialty Physicians Advancing Rural Care (SPARC) Act
Healthcare Workforce Issues
Healthy at Home Act
Lower Costs, More Transparency Act
Bipartisan Primary Care and Health Workforce Act
PBM Reforms
Agencies Lobbied
U.S. Senate
Lobbying Issues
Making epinephrine for anaphylaxis available on airplanes
FAA Reviews of Airline Emergency Medical Kit Content List
Agencies Lobbied
U.S. Senate
2nd Quarter, 2023
In Q2, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $40,000. The report was filed on July 18, 2023.
Original Filing: 301480305.xml
Lobbying Issues
Appropriations for Children's Asthma Treatment Grants Program.
Support for funding the Consortium of Food Allergy Research at the NIAID.
Support funding for food allergy research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 2474
Legislation affecting the Medicare Physician Fee Schedule.
COVID-19 PHE Waivers
Issues concerning physician participation in MIPS and Alternative Payment Models.
Expanding Medicare coverage for telehealth.
Medicare prescription drug prices
Network Adequacy for Health Plans
Prior authorization in Medicare Advantage plans
PBM Issues
Agencies Lobbied
U.S. Senate
Lobbying Issues
American Rescue Plan implementation
No Surprises Act Implementation
Proposals to reform prescription drug pricing
COVID-19 PHE Waivers
Heat and Smoke-Related Air Quality Impact on Health
Specialty Physicians Advancing Rural Care (SPARC) Act
Healthcare Workforce Issues
Agencies Lobbied
U.S. Senate
Lobbying Issues
Epinephrine autoinjector availability on airplanes
FAA Reviews of Airline Emergency Medical Kit Content List
Agencies Lobbied
U.S. Senate
1st Quarter, 2023
CAPITOL ASSOCIATES, INC. amended a lobbying report for representation of JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI in Q12023 on May 8, 2023.
Original Filing: 301470615.xml
Lobbying Issues
Appropriations for Children's Asthma Treatment Grants Program.
Support for funding the Consortium of Food Allergy Research at the NIAID.
Support funding for food allergy research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 2474
Legislation affecting the Medicare Physician Fee Schedule.
COVID-19 PHE Waivers
Issues concerning physician participation in MIPS and Alternative Payment Models.
Expanding Medicare coverage for telehealth.
Medicare prescription drug prices
Network Adequacy for Health Plans
Prior authorization in Medicare Advantage plans
Agencies Lobbied
U.S. Senate
Lobbying Issues
American Rescue Plan implementation
No Surprises Act Implementation
Proposals to reform prescription drug pricing
COVID-19 PHE Waivers
Epinephrine autoinjector availability on airplanes
Agencies Lobbied
U.S. Senate
1st Quarter, 2023
In Q1, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $40,000. The report was filed on April 20, 2023.
Original Filing: 301460780.xml
Lobbying Issues
Appropriations for Children's Asthma Treatment Grants Program.
Support for funding the Consortium of Food Allergy Research at the NIAID.
Support funding for food allergy research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 2474
Legislation affecting the Medicare Physician Fee Schedule.
COVID-19 PHE Waivers
Issues concerning physician participation in MIPS and Alternative Payment Models.
Expanding Medicare coverage for telehealth.
Medicare prescription drug prices
Network Adequacy for Health Plans
Prior authorization in Medicare Advantage plans
Agencies Lobbied
U.S. Senate
Lobbying Issues
American Rescue Plan implementation
No Surprises Act Implementation
Proposals to reform prescription drug pricing
COVID-19 PHE Waivers
Epinephrine autoinjector availability on airplanes
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $40,000. The report was filed on Jan. 19, 2023.
Original Filing: 301434371.xml
Lobbying Issues
Appropriations for Children's Asthma Treatment Grants Program.
Support for funding the Consortium of Food Allergy Research at the NIAID.
Support funding for food allergy research.
H.R.2617 - Consolidated Appropriations Act, 2023
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to waive the PAYGO Medicare cuts associated with the American Rescue Plan.
Legislation affecting the Medicare Physician Fee Schedule.
COVID-19 Relief Programs including the Provider Relief Fund.
Concerns about the Physician-Focused Payment Model review/approval process.
Issues concerning physician participation in MIPS and Alternative Payment Models.
Expanding Medicare coverage for telehealth.
Medicare prescription drug prices.
Network Adequacy for Health Plans.
Prior authorization in Medicare Advantage plans.
Legislation preventing Medicare cuts from taking effect in 2023.
Agencies Lobbied
U.S. Senate
Lobbying Issues
American Rescue Plan implementation.
No Surprises Act Implementation.
Proposals to reform prescription drug pricing.
COVID-19 assistance programs including Provider Relief Fund.
Network Adequacy for Health Plans.
S. 578, FASTER Act
H.R.2547 - Comprehensive Debt Collection Improvement Act
Epinephrine autoinjector availability on airplanes.
Prescription Drug User Fee Reauthorization
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $40,000. The report was filed on Oct. 18, 2022.
Original Filing: 301407589.xml
Lobbying Issues
Appropriations for Children's Asthma Treatment Grants Program.
Support for funding the Consortium of Food Allergy Research at the NIAID.
Support funding for food allergy research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to waive the PAYGO Medicare cuts associated with the American Rescue Plan.
Legislation affecting the Medicare Physician Fee Schedule.
COVID-19 Relief Programs including the Provider Relief Fund.
Concerns about the Physician-Focused Payment Model review/approval process.
Issues concerning physician participation in MIPS and Alternative Payment Models.
Expanding Medicare coverage for telehealth.
Medicare prescription drug prices.
Network Adequacy for Health Plans.
Prior authorization in Medicare Advantage plans.
Agencies Lobbied
U.S. Senate
Lobbying Issues
American Rescue Plan implementation.
No Surprises Act Implementation.
Proposals to reform prescription drug pricing.
COVID-19 assistance programs including Provider Relief Fund.
Network Adequacy for Health Plans.
S. 578, FASTER Act
H.R.2547 - Comprehensive Debt Collection Improvement Act
Epinephrine autoinjector availability on airplanes.
Prescription Drug User Fee Reauthorization
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $40,000. The report was filed on July 18, 2022.
Original Filing: 301383588.xml
Lobbying Issues
Appropriations for Children's Asthma Treatment Grants Program.
Support for funding the Consortium of Food Allergy Research at the NIAID.
Support funding for food allergy research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to waive the PAYGO Medicare cuts associated with the American Rescue Plan.
Legislation affecting the Medicare Physician Fee Schedule.
COVID-19 Relief Programs including the Provider Relief Fund.
Concerns about the Physician-Focused Payment Model review/approval process.
Issues concerning physician participation in MIPS and Alternative Payment Models.
Expanding Medicare coverage for telehealth.
Medicare prescription drug prices.
Network Adequacy for Health Plans.
Prior authorization in Medicare Advantage plans.
Agencies Lobbied
U.S. Senate
Lobbying Issues
American Rescue Plan implementation.
No Surprises Act Implementation.
Proposals to reform prescription drug pricing.
COVID-19 assistance programs including Provider Relief Fund.
Network Adequacy for Health Plans.
S. 578, FASTER Act
H.R.2547 - Comprehensive Debt Collection Improvement Act
Epinephrine autoinjector availability on airplanes.
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $40,000. The report was filed on April 20, 2022.
Original Filing: 301365873.xml
Lobbying Issues
Appropriations for Children's Asthma Treatment Grants Program.
Support for funding the Consortium of Food Allergy Research at the NIAID.
Support funding for food allergy research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to waive the PAYGO Medicare cuts associated with the American Rescue Plan.
Legislation affecting the Medicare Physician Fee Schedule.
COVID-19 Relief Programs including the Provider Relief Fund.
Concerns about the Physician-Focused Payment Model review/approval process.
Issues concerning physician participation in MIPS and Alternative Payment Models.
Expanding Medicare coverage for telehealth.
Medicare prescription drug prices.
Network Adequacy for Health Plans.
Agencies Lobbied
U.S. Senate
Lobbying Issues
American Rescue Plan implementation policy
No Surprises Act Implementation.
Proposals to reform prescription drug pricing.
COVID-19 assistance programs including Provider Relief Fund.
Network Adequacy for Health Plans.
S. 578, FASTER Act
H.R.2547 - Comprehensive Debt Collection Improvement Act
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $40,000. The report was filed on Jan. 19, 2022.
Original Filing: 301329633.xml
Lobbying Issues
Appropriations for Children's Asthma Treatment Grants Program.
Support for funding the Consortium of Food Allergy Research at the NIAID.
Support funding for food allergy research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 1868
Legislation to waive the PAYGO Medicare cuts in FY 2022 associated with the American Rescue Plan.
Legislation affecting the Medicare Physician Fee Schedule.
COVID-19 Relief Programs including the Provider Relief Fund.
Concerns about the Physician-Focused Payment Model review/approval process.
Issues concerning physician participation in MIPS and Alternative Payment Models.
Expanding Medicare coverage for telehealth.
Medicare prescription drug prices.
Network Adequacy for Health Plans.
Agencies Lobbied
U.S. Senate
Lobbying Issues
American Rescue Plan implementation policy
No Surprises Act Implementation.
Proposals to reform prescription drug pricing.
COVID-19 assistance programs including Provider Relief Fund.
Network Adequacy for Health Plans.
S. 578, FASTER Act
H.R.2547 - Comprehensive Debt Collection Improvement Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $40,000. The report was filed on Oct. 13, 2021.
Original Filing: 301298359.xml
Lobbying Issues
Appropriations for Children's Asthma Treatment Grants Program.
Support for funding the Consortium of Food Allergy Research at the NIAID.
Support funding for food allergy research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 1868
Legislation to waive the PAYGO Medicare cuts in FY 2022 associated with the American Rescue Plan.
Legislation affecting the Medicare Physician Fee Schedule.
COVID-19 Relief Programs including the Provider Relief Fund.
Concerns about the Physician-Focused Payment Model review/approval process.
Issues concerning physician participation in MIPS and Alternative Payment Models.
Expanding Medicare coverage for telehealth.
Medicare prescription drug prices.
Network Adequacy for Health Plans.
Agencies Lobbied
U.S. Senate
Lobbying Issues
American Rescue Plan implementation policy
No Surprises Act Implementation.
Proposals to reform prescription drug pricing.
COVID-19 assistance programs including Provider Relief Fund.
Network Adequacy for Health Plans.
S. 578, FASTER Act
H.R.2547 - Comprehensive Debt Collection Improvement Act
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $40,000. The report was filed on July 16, 2021.
Original Filing: 301277462.xml
Lobbying Issues
Appropriations for Children's Asthma Treatment Grants Program.
Support for funding the Consortium of Food Allery Research at the NIAID.
Support funding for food allergy research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 1868
Legislation to waive the PAYGO Medicare cuts in FY 2022 associated with the American Rescue Plan.
Legislation affecting the Medicare Physician Fee Schedule.
COVID-19 Relief Programs including the Provider Relief Fund.
Concerns about the Physician-Focused Payment Model review/approval process.
Issues concerning physician participation in MIPS and Alternative Payment Models.
Expanding Medicare coverage for telehealth.
Medicare prescription drug prices.
Network Adequacy for Health Plans.
Agencies Lobbied
U.S. Senate
Lobbying Issues
American Rescue Plan.
No Surprises Act Implementation.
Proposals to reform prescription drug pricing.
COVID-19 assistance programs including Provider Relief Fund.
Network Adequacy for Health Plans.
S. 578, FASTER Act
H.R.2547 - Comprehensive Debt Collection Improvement Act
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $40,000. The report was filed on April 16, 2021.
Original Filing: 301254486.xml
Lobbying Issues
Appropriations for Children's Asthma Treatment Grants Program.
Support for funding the Consortium of Food Allery Research at the NIAID.
Support funding for food allergy research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 1868
Legislation to waive the PAYGO Medicare cuts in FY 2022 associated with the American Rescue Plan.
Legislation affecting the Medicare Physician Fee Schedule.
COVID-19 Relief Programs including the Provider Relief Fund.
Concerns about the Physician-Focused Payment Model review/approval process.
Issues concerning physician participation in MIPS and Alternative Payment Models.
Expanding Medicare coverage for telehealth.
Medicare prescription drug prices.
Network Adequacy for Health Plans.
Agencies Lobbied
U.S. Senate
Lobbying Issues
American Rescue Plan.
No Surprises Act Implementation.
Proposals to reform prescription drug pricing.
COVID-19 assistance programs including Provider Relief Fund.
Network Adequacy for Health Plans.
S. 578, FASTER Act
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $30,000. The report was filed on Jan. 19, 2021.
Original Filing: 301235721.xml
Lobbying Issues
H.R. 2740, the FY 2020 Labor/HHS Appropriations bill, funding for food allergy research
Funding for asthma and allergy programs, healthcare quality and health information technology in the FY 2020 Labor/HHS Appropriations bill.
Support for funding the Consortium of Food Allergy Research at the National Institute of Allergy and Infectious Diseases
Increase funding for Peanut Allergy education
FY 2021 Appropriations for the Department of Health and Human Services (HHS)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation affecting Medicare Physician Fee Schedule
Concerns about the Physician Focused Payment Model review/approval process
Alternative Payment Models
Patients over Paperwork initiative
Medicare telehealth policy
Possible changes to 340B program
Possible changes to pharmaceutical pricing and federal mandates (international pricing model) for physician administered drugs
Federal legislation addressing so-called surprise medical bills
Network Adequacy for Health Plans
Provider Relief funding and the formula for determining payments
expansion of telehealth benefit including authority to use land-line telephone for telehealth visits
Support for allowing physicians to engage in cross-stateline telehealth visits.
Promotion of Asthma Care Alternative Payment model to Physician Focused Technical Advisory Committee (PTAC)
CARES Act
Waivers for provision of telehealth services during COVID-19
Medicare COVID related waivers including telehealth waivers
Agencies Lobbied
U.S. Senate
Lobbying Issues
Possible changes to pharmaceutical pricing and federal mandates (international pricing model)
Federal legislation addressing so-called surprise medical bills
Network Adequacy for Health Plans
Provider Relief Funds included in CARES Act
H.R. 2468, School-Based Allergies and Asthma Management Program Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $30,000. The report was filed on Oct. 19, 2020.
Original Filing: 301213261.xml
Lobbying Issues
H.R. 2740, the FY 2020 Labor/HHS Appropriations bill, funding for food allergy research
Funding for asthma and allergy programs, healthcare quality and health information technology in the FY 2020 Labor/HHS Appropriations bill.
Support for funding the Consortium of Food Allergy Research at the National Institute of Allergy and Infectious Diseases
Increase funding for Peanut Allergy education
FY 2021 Appropriations for the Department of Health and Human Services (HHS)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation affecting Medicare Physician Fee Schedule
Concerns about the Physician Focused Payment Model review/approval process
Alternative Payment Models
Patients over Paperwork initiative
Medicare telehealth policy
Possible changes to 340B program
Possible changes to pharmaceutical pricing and federal mandates (international pricing model) for physician administered drugs
Federal legislation addressing so-called surprise medical bills
Network Adequacy for Health Plans
Provider Relief funding and the formula for determining payments
expansion of telehealth benefit including authority to use land-line telephone for telehealth visits
Support for allowing physicians to engage in cross-stateline telehealth visits.
Promotion of Asthma Care Alternative Payment model to Physician Focused Technical Advisory Committee (PTAC)
CARES Act
Waivers for provision of telehealth services during COVID-19
Medicare COVID related waivers including telehealth waivers
Agencies Lobbied
U.S. Senate
Lobbying Issues
Possible changes to pharmaceutical pricing and federal mandates (international pricing model)
Federal legislation addressing so-called surprise medical bills
Network Adequacy for Health Plans
Provider Relief Funds included in CARES Act
H.R. 2468, School-Based Allergies and Asthma Management Program Act
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $30,000. The report was filed on July 20, 2020.
Original Filing: 301198250.xml
Lobbying Issues
H.R. 2740, the FY 2020 Labor/HHS Appropriations bill, funding for food allergy research
Funding for asthma and allergy programs, healthcare quality and health information technology in the FY 2020 Labor/HHS Appropriations bill.
Support for funding the Consortium of Food Allergy Research at the National Institute of Allergy and Infectious Diseases
Increase funding for Peanut Allergy education
FY 2021 Appropriations for the Department of Health and Human Services (HHS)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation affecting Medicare Physician Fee Schedule
Concerns about the Physician Focused Payment Model review/approval process
Alternative Payment Models
Patients over Paperwork initiative
Medicare telehealth policy
Possible changes to 340B program
Possible changes to pharmaceutical pricing and federal mandates (international pricing model) for physician administered drugs
Federal legislation addressing so-called surprise medical bills
Network Adequacy for Health Plans
Provider Relief funding and the formula for determining payments
expansion of telehealth benefit including authority to use land-line telephone for telehealth visits
Support for allowing physicians to engage in cross-stateline telehealth visits.
Promotion of Asthma Care Alternative Payment model to Physician Focused Technical Advisory Committee (PTAC)
CARES Act
Waivers for provision of telehealth services during COVID-19
Agencies Lobbied
U.S. Senate
Lobbying Issues
Possible changes to pharmaceutical pricing and federal mandates (international pricing model)
Federal legislation addressing so-called surprise medical bills
Network Adequacy for Health Plans
Provider Relief Funds included in CARES Act
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $30,000. The report was filed on April 16, 2020.
Original Filing: 301168564.xml
Lobbying Issues
H.R. 2740, the FY 2020 Labor/HHS Appropriations bill, funding for food allergy research
Funding for asthma and allergy programs, healthcare quality and health information technology in the FY 2020 Labor/HHS Appropriations bill.
Support for funding the Consortium of Food Allergy Research at the National Institute of Allergy and Infectious Diseases
Increase funding for Peanut Allergy education
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation affecting Medicare Physician Fee Schedule
Concerns about the Physician Focused Payment Model review/approval process
Alternative Payment Models
Patients over Paperwork initiative
Medicare telehealth policy
Possible changes to 340B program
Possible changes to pharmaceutical pricing and federal mandates (international pricing model) for physician administered drugs
Federal legislation addressing so-called surprise medical bills
Network Adequacy for Health Plans
Provider Relief funding and the formula for determining payments
expansion of telehealth benefit including authority to use land-line telephone for telehealth visits
Support for allowing physicians to engage in cross-stateline telehealth visits.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Possible changes to pharmaceutical pricing and federal mandates (international pricing model)
Federal legislation addressing so-called surprise medical bills
Network Adequacy for Health Plans
Provider Relief Funds included in CARES Act
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $30,000. The report was filed on Jan. 21, 2020.
Original Filing: 301126349.xml
Lobbying Issues
H.R. 2740, the FY 2020 Labor/HHS Appropriations bill, funding for food allergy research
Funding for asthma and allergy programs, healthcare quality and health information technology in the FY 2020 Labor/HHS Appropriations bill.
Support for funding the Consortium of Food Allergy Research at the National Institute of Allergy and Infectious Diseases
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation affecting Medicare Physician Fee Schedule
Concerns about the Physician Focused Payment Model review/approval process
Alternative Payment Models
Patients over Paperwork initiative
Medicare telehealth policy
Possible changes to 340B program
Possible changes to pharmaceutical pricing and federal mandates (international pricing model) for physician administered drugs
Federal legislation addressing so-called surprise medical bills
Network Adequacy for Health Plans
Agencies Lobbied
U.S. Senate
Lobbying Issues
Possible changes to pharmaceutical pricing and federal mandates (international pricing model)
Federal legislation addressing so-called surprise medical bills
Network Adequacy for Health Plans
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $30,000. The report was filed on Oct. 15, 2019.
Original Filing: 301065410.xml
Lobbying Issues
H.R. 2740, the FY 2020 Labor/HHS Appropriations bill, funding for food allergy research
Funding for asthma and allergy programs, healthcare quality and health information technology in the FY 2020 Labor/HHS Appropriations bill.
Support for funding the Consortium of Food Allergy Research at the National Institute of Allergy and Infectious Diseases
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation affecting Medicare Physician Fee Schedule
Concerns about the Physician Focused Payment Model review/approval process
Alternative Payment Models
Patients over Paperwork initiative
Medicare telehealth policy
Possible changes to 340B program
Possible changes to pharmaceutical pricing and federal mandates (international pricing model) for physician administered drugs
Federal legislation addressing so-called surprise medical bills
Network Adequacy for Health Plans
Agencies Lobbied
U.S. Senate
Lobbying Issues
Possible changes to pharmaceutical pricing and federal mandates (international pricing model)
Federal legislation addressing so-called surprise medical bills
Network Adequacy for Health Plans
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $30,000. The report was filed on July 11, 2019.
Original Filing: 301044460.xml
Lobbying Issues
H.R. 2740, the FY 2020 Labor/HHS Appropriations bill, funding for food allergy research
Funding for asthma and allergy programs, healthcare quality and health information technology in the FY 2020 Labor/HHS Appropriations bill.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation affecting Medicare Physician Fee Schedule
Concerns about the Physician Focused Payment Model review/approval process
Alternative Payment Models
Patients over Paperwork initiative
Medicare telehealth policy
Possible changes to 340B program
Possible changes to pharmaceutical pricing and federal mandates (international pricing model) for physician administered drugs
Federal legislation addressing so-called surprise medical bills
Network Adequacy for Health Plans
Agencies Lobbied
U.S. Senate
Lobbying Issues
Possible changes to pharmaceutical pricing and federal mandates (international pricing model)
Federal legislation addressing so-called surprise medical bills
Network Adequacy for Health Plans
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $30,000. The report was filed on April 19, 2019.
Original Filing: 301030801.xml
Lobbying Issues
FY 2020 Labor/HHS Appropriations for food allergy research
Funding for asthma and allergy programs, healthcare quality and health information technology in the FY 2020 Labor/HHS Appropriations bill.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation affecting Medicare Physician Fee Schedule
Concerns about the Physician Focused Payment Model review/approval process
Alternative Payment Models
Patients over Paperwork initiative
Medicare telehealth policy
Possible changes to 340B program
Possible changes to pharmaceutical pricing and federal mandates (international pricing model) for physician administered drugs
Federal legislation addressing so-called surprise medical bills
Network Adequacy for Health Plans
Agencies Lobbied
U.S. Senate
Lobbying Issues
Possible changes to pharmaceutical pricing and federal mandates (international pricing model)
Federal legislation addressing so-called surprise medical bills
Network Adequacy for Health Plans
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $30,000. The report was filed on Jan. 17, 2019.
Original Filing: 301007023.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare in the appropriations bill for the Department of Health and Human Services for FY 2017.
Medicare payment cuts affecting physicians due to Sequestration.
FDA appropriations as included in the Agriculture Appropriations bill for FY 2019.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education.
Support to repeal IPAB.
Patients over paper work initiative
Regulations implementing Affordable Care Act, HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records for ICD-10.
Possible reforms to Medicare Graduate Medical Education funding.
Regulations implementing the Medicare Access and CHIP Reauthorization Act of 2015.
Regulations proposing changes to the Part B Drug Payment Model (CMS-1670-P).
Support for Medicare Telehealth Parity
Medicare Physician Fee Schedule issues
Support for continuation of Medicare Demonstration project for Medicare IVIG Therapy Access
support for reauthorization of the CHIP program
Possible changes to the 340B Prescription drug program
Issues related to development of alternative payment models
Proposed changes to E/M coding documentation and Medicare payments
Development and approval of Alternative Payment Models by CMMI using Physician Focused Payment Model process
Agencies Lobbied
U.S. Senate
Lobbying Issues
FDA Conflict of Interest issue, Compounding issue and implementation of FDA regulations and FDA issues affecting Allergists and their patients.
Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform.
Support Health Care Truth & Transparency Act.
Support authorization of Children Hospital Graduate Medical Education program.
Issues of network adequacy in Qualified Health Plans and its impact on patients with chronic diseases.
ACA implementation in general and its impact on workforce and supply.
Development of Alternative payment Models and development of bundled payments for asthma care.
Support School-Based Asthma Management Program Act.
Regulations restricting smoking in Federal housing complex.
Encourage Members of Congress to join the Allergy Caucus
Support legislation Federal designed to address step-therapy issues
Support for continuation of Medicare Demonstration of IVIG Therapy
Proposed FDA Guidance document for compounding/mixing of allergy extracts
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $30,000. The report was filed on Oct. 22, 2018.
Original Filing: 300995401.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare in the appropriations bill for the Department of Health and Human Services for FY 2017.
Medicare payment cuts affecting physicians due to Sequestration.
FDA appropriations as included in the Agriculture Appropriations bill for FY 2019.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education.
Support to repeal IPAB.
Patients over paper work initiative
Regulations implementing Affordable Care Act, HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records for ICD-10.
Possible reforms to Medicare Graduate Medical Education funding.
Regulations implementing the Medicare Access and CHIP Reauthorization Act of 2015.
Regulations proposing changes to the Part B Drug Payment Model (CMS-1670-P).
Support for Medicare Telehealth Parity
Medicare Physician Fee Schedule issues
Support for continuation of Medicare Demonstration project for Medicare IVIG Therapy Access
support for reauthorization of the CHIP program
Possible changes to the 340B Prescription drug program
Issues related to development of alternative payment models
Proposed changes to E/M coding documentation and Medicare payments
Agencies Lobbied
U.S. Senate
Lobbying Issues
FDA Conflict of Interest issue, Compounding issue and implementation of FDA regulations and FDA issues affecting Allergists and their patients.
Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform.
Support Health Care Truth & Transparency Act.
Support authorization of Children Hospital Graduate Medical Education program.
Issues of network adequacy in Qualified Health Plans and its impact on patients with chronic diseases.
ACA implementation in general and its impact on workforce and supply.
Development of Alternative payment Models and development of bundled payments for asthma care.
Support School-Based Asthma Management Program Act.
Regulations restricting smoking in Federal housing complex.
Encourage Members of Congress to join the Allergy Caucus
Support legislation Federal designed to address step-therapy issues
Support for continuation of Medicare Demonstration of IVIG Therapy
Proposed FDA Guidance document for compounding/mixing of allergy extracts
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $30,000. The report was filed on Aug. 21, 2018.
Original Filing: 300981116.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare in the appropriations bill for the Department of Health and Human Services for FY 2017.
Medicare payment cuts affecting physicians due to Sequestration.
FDA appropriations as included in the Agriculture Appropriations bill for FY 2019.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education.
Support to repeal IPAB.
Patients over paper work initiative
Regulations implementing Affordable Care Act, HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records for ICD-10.
Possible reforms to Medicare Graduate Medical Education funding.
Regulations implementing the Medicare Access and CHIP Reauthorization Act of 2015.
Regulations proposing changes to the Part B Drug Payment Model (CMS-1670-P).
Support for Medicare Telehealth Parity
Medicare Physician Fee Schedule issues
Support for continuation of Medicare Demonstration project for Medicare IVIG Therapy Access
support for reauthorization of the CHIP program
Possible changes to the 340B Prescription drug program
Issues related to development of alternative payment models
Agencies Lobbied
U.S. Senate
Lobbying Issues
FDA Conflict of Interest issue, Compounding issue and implementation of FDA regulations and FDA issues affecting Allergists and their patients.
Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform.
Support Health Care Truth & Transparency Act.
Support authorization of Children Hospital Graduate Medical Education program.
Issues of network adequacy in Qualified Health Plans and its impact on patients with chronic diseases.
ACA implementation in general and its impact on workforce and supply.
Development of Alternative payment Models and development of bundled payments for asthma care.
Support School-Based Asthma Management Program Act.
Regulations restricting smoking in Federal housing complex.
Encourage Members of Congress to join the Allergy Caucus
Support legislation Federal designed to address step-therapy issues
Support for continuation of Medicare Demonstration of IVIG Therapy
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $30,000. The report was filed on April 20, 2018.
Original Filing: 300956021.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare in the appropriations bill for the Department of Health and Human Services for FY 2017.
Medicare payment cuts affecting physicians due to Sequestration.
FDA appropriations as included in the Agriculture Appropriations bill in FY 2017.
FDA appropriations as included in the Agriculture Appropriations bill for FY 2018.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education.
Support to repeal IPAB.
Patients over paper work initiative
Regulations implementing Affordable Care Act, HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records for ICD-10.
Possible reforms to Medicare Graduate Medical Education funding.
Regulations implementing the Medicare Access and CHIP Reauthorization Act of 2015.
Regulations proposing changes to the Part B Drug Payment Model (CMS-1670-P).
Support for Medicare Telehealth Parity
Medicare Physician Fee Schedule issues
Support for continuation of Medicare Demonstration project for Medicare IVIG Therapy Access
support for reauthorization of the CHIP program
Possible changes to the 340B Prescription drug program
Issues related to development of alternative payment models
Agencies Lobbied
U.S. Senate
Lobbying Issues
FDA Conflict of Interest issue, Compounding issue and implementation of FDA regulations and FDA issues affecting Allergists and their patients.
Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform.
Support Health Care Truth & Transparency Act.
Support authorization of Children Hospital Graduate Medical Education program.
Issues of network adequacy in Qualified Health Plans and its impact on patients with chronic diseases.
ACA implementation in general and its impact on workforce and supply.
Development of Alternative payment Models and development of bundled payments for asthma care.
Support School-Based Asthma Management Program Act.
Regulations restricting smoking in Federal housing complex.
Encourage Members of Congress to join the Allergy Caucus
Support legislation Federal designed to address step-therapy issues
Support for continuation of Medicare Demonstration of IVIG Therapy
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
In Q4, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $30,000. The report was filed on Jan. 18, 2018.
Original Filing: 300927388.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare in the appropriations bill for the Department of Health and Human Services for FY 2017.
Medicare payment cuts affecting physicians due to Sequestration.
FDA appropriations as included in the Agriculture Appropriations bill in FY 2017.
FDA appropriations as included in the Agriculture Appropriations bill for FY 2018.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education.
Support to repeal IPAB.
Regulations implementing Affordable Care Act, HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records for ICD-10.
Possible reforms to Medicare Graduate Medical Education funding.
Regulations implementing the Medicare Access and CHIP Reauthorization Act of 2015.
Regulations proposing changes to the Part B Drug Payment Model (CMS-1670-P).
Support for Medicare Telehealth Parity
Medicare Physician Fee Schedule issues
Support for continuation of Medicare Demonstration project for Medicare IVIG Therapy Access
support for reauthorization of the CHIP program
Possible changes to the 340B Prescription drug program
Agencies Lobbied
U.S. Senate
Lobbying Issues
FDA Conflict of Interest issue, Compounding issue and implementation of FDA regulations and FDA issues affecting Allergists and their patients.
Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform.
Support Health Care Truth & Transparency Act.
Support authorization of Children Hospital Graduate Medical Education program.
Issues of network adequacy in Qualified Health Plans and its impact on patients with chronic diseases.
ACA implementation in general and its impact on workforce and supply.
Development of Alternative payment Models and development of bundled payments for asthma care.
Support School-Based Asthma Management Program Act.
Regulations restricting smoking in Federal housing complex.
Encourage Members of Congress to join the Allergy Caucus
Support legislation Federal designed to address step-therapy issues
Support for continuation of Medicare Demonstration of IVIG Therapy
Agencies Lobbied
U.S. Senate
3rd Quarter, 2017
In Q3, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $30,000. The report was filed on Oct. 16, 2017.
Original Filing: 300904208.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare in the appropriations bill for the Department of Health and Human Services for FY 2017.
Medicare payment cuts affecting physicians due to Sequestration.
FDA appropriations as included in the Agriculture Appropriations bill in FY 2017.
FDA appropriations as included in the Agriculture Appropriations bill for FY 2018.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education.
Support to repeal IPAB.
Regulations implementing Affordable Care Act, HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records for ICD-10.
Possible reforms to Medicare Graduate Medical Education funding.
Regulations implementing the Medicare Access and CHIP Reauthorization Act of 2015.
Regulations proposing changes to the Part B Drug Payment Model (CMS-1670-P).
Support for Medicare Telehealth Parity
Medicare Physician Fee Schedule issues
Support for continuation of Medicare Demonstration project for Medicare IVIG Therapy Access
Agencies Lobbied
U.S. Senate
Lobbying Issues
FDA Conflict of Interest issue, Compounding issue and implementation of FDA regulations and FDA issues affecting Allergists and their patients.
Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform.
Support Health Care Truth & Transparency Act.
Support authorization of Children Hospital Graduate Medical Education program.
Issues of network adequacy in Qualified Health Plans and its impact on patients with chronic diseases.
ACA implementation in general and its impact on workforce and supply.
Development of Alternative payment Models and development of bundled payments for asthma care.
Support School-Based Asthma Management Program Act.
Regulations restricting smoking in Federal housing complex.
Encourage Members of Congress to join the Allergy Caucus
Support legislation Federal designed to address step-therapy issues
Support for continuation of Medicare Demonstration of IVIG Therapy
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
In Q2, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $30,000. The report was filed on July 19, 2017.
Original Filing: 300890519.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare in the appropriations bill for the Department of Health and Human Services for FY 2017.
Medicare payment cuts affecting physicians due to Sequestration.
FDA appropriations as included in the Agriculture Appropriations bill in FY 2017.
FDA appropriations as included in the Agriculture Appropriations bill for FY 2018.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education.
Support to repeal IPAB.
Regulations implementing Affordable Care Act, HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records for ICD-10.
Possible reforms to Medicare Graduate Medical Education funding.
Regulations implementing the Medicare Access and CHIP Reauthorization Act of 2015.
Regulations proposing changes to the Part B Drug Payment Model (CMS-1670-P).
Support for Medicare Telehealth Parity
Medicare Physician Fee Schedule issues
Agencies Lobbied
U.S. Senate
Lobbying Issues
FDA Conflict of Interest issue, Compounding issue and implementation of FDA regulations and FDA issues affecting Allergists and their patients.
Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform.
Support Health Care Truth & Transparency Act.
Support authorization of Children Hospital Graduate Medical Education program.
Issues of network adequacy in Qualified Health Plans and its impact on patients with chronic diseases.
ACA implementation in general and its impact on workforce and supply.
Development of Alternative payment Models and development of bundled payments for asthma care.
Support School-Based Asthma Management Program Act.
Regulations restricting smoking in Federal housing complex.
Encourage Members of Congress to join the Allergy Caucus
Support legislation Federal designed to address step-therapy issues
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $30,000. The report was filed on April 14, 2017.
Original Filing: 300865511.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare in the appropriations bill for the Department of Health and Human Services for FY 2017.
Medicare payment cuts affecting physicians due to Sequestration.
FDA appropriations as included in the Agriculture Appropriations bill in FY 2017.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education.
Support to repeal IPAB.
Regulations implementing Affordable Care Act, HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records for ICD-10.
Possible reforms to Medicare Graduate Medical Education funding.
Regulations implementing the Medicare Access and CHIP Reauthorization Act of 2015.
Regulations proposing changes to the Part B Drug Payment Model (CMS-1670-P).
Support for Medicare Telehealth Parity
Agencies Lobbied
U.S. Senate
Lobbying Issues
FDA Conflict of Interest issue, Compounding issue and implementation of FDA regulations and FDA issues affecting Allergists and their patients.
Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform.
Support Health Care Truth & Transparency Act.
Support authorization of Children Hospital Graduate Medical Education program.
Issues of network adequacy in Qualified Health Plans and its impact on patients with chronic diseases.
ACA implementation in general and its impact on workforce and supply.
Development of Alternative payment Models and development of bundled payments for asthma care.
Support School-Based Asthma Management Program Act.
Regulations restricting smoking in Federal housing complex.
Encourage Members of Congress to join the Allergy Caucus
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $30,000. The report was filed on Jan. 11, 2017.
Original Filing: 300845000.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education, graduate medical education and health information technology initiatives and Medicaid/Medicare in the appropriations bill for the Department of Health and Human Services for FY 2016.
Medicare payment cuts affecting physicians due to Sequestration.
FDA appropriations as included in the Agriculture Appropriations bill for FY 2017
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education.
Support to repeal IPAB.
Regulations implementing Affordable Care Act, HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records and ICD-10.
Possible reforms to Medicare Graduate Medical Education funding.
Regulations implementing the Medicare Access and CHIP Reauthorization Act of 2015
Regulations proposing changes to the Part B Drug Payment Model(CMS-1670-P)
Support for H.R. 2948 - Medicare Telehealth Parity Act of 2015
Agencies Lobbied
U.S. Senate
Lobbying Issues
FDA Conflict of Interest issue,Compounding issue and implementation of FDA regulations and FDA issues affecting Allergists and their patients.
Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform.
Support Health Care Truth & Transparency Act.
Support authorization of Children Hospital Graduate Medical Education program.
Issues of network adequacy in Qualified Health Plans and its impact on patients with chronic diseases.
ACA implementation in general and its impact on workforce and supply.
Development of Alternative Payment Models and development of bundled payments for asthma care.
Support H.R. 4662 - School-Based Asthma Management Program Act
Regulations restricting smoking in federal housing complex
Agencies Lobbied
U.S. Senate
3rd Quarter, 2016
In Q3, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $30,000. The report was filed on Oct. 11, 2016.
Original Filing: 300826300.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education, graduate medical education and health information technology initiatives and Medicaid/Medicare in the appropriations bill for the Department of Health and Human Services for FY 2016.
Medicare payment cuts affecting physicians due to Sequestration.
FDA appropriations as included in the Agriculture Appropriations bill for FY 2017
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education.
Support to repeal IPAB.
Regulations implementing Affordable Care Act, HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records and ICD-10.
Possible reforms to Medicare Graduate Medical Education funding.
Regulations implementing the Medicare Access and CHIP Reauthorization Act of 2015
Regulations proposing changes to the Part B Drug Payment Model(CMS-1670-P)
Support for H.R. 2948 - Medicare Telehealth Parity Act of 2015
Agencies Lobbied
U.S. Senate
Lobbying Issues
FDA Conflict of Interest issue,Compounding issue and implementation of FDA regulations and FDA issues affecting Allergists and their patients.
Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform.
Support Health Care Truth & Transparency Act.
Support authorization of Children Hospital Graduate Medical Education program.
Issues of network adequacy in Qualified Health Plans and its impact on patients with chronic diseases.
ACA implementation in general and its impact on workforce and supply.
Development of Alternative Payment Models and development of bundled payments for asthma care.
Support H.R. 4662 - School-Based Asthma Management Program Act
Regulations restricting smoking in federal housing complex
Agencies Lobbied
U.S. Senate
2nd Quarter, 2016
In Q2, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $30,000. The report was filed on July 19, 2016.
Original Filing: 300812836.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education, graduate medical education and health information technology initiatives and Medicaid/Medicare in the appropriations bill for the Department of Health and Human Services for FY 2016.
Medicare payment cuts affecting physicians due to Sequestration.
FDA appropriations as included in the Agriculture Appropriations bill for FY 2017
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education.
Support to repeal IPAB.
Regulations implementing Affordable Care Act, HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records and ICD-10.
Reauthorization of the Children's Health Insurance Program (CHIP).
Possible reforms to Medicare Graduate Medical Education funding.
Regulations implementing the Medicare Access and CHIP Reauthorization Act of 2015
Regulations proposing changes to the Part B Drug Payment Model(CMS-1670-P)
Support for H.R. 2948 - Medicare Telehealth Parity Act of 2015
Agencies Lobbied
U.S. Senate
Lobbying Issues
FDA Conflict of Interest issue,Compounding issue and implementation of FDA regulations and FDA issues affecting Allergists and their patients.
Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform.
Support Health Care Truth & Transparency Act.
Support authorization of Children Hospital Graduate Medical Education program.
Issues of network adequacy in Qualified Health Plans and its impact on patients with chronic diseases.
Support reauthorization of the Children's Health Insurance Program (CHIP).
ACA implementation in general and its impact on workforce and supply.
Development of Alternative Payment Models and development of bundled payments for asthma care.
Support H.R. 4662 - School-Based Asthma Management Program Act
Regulations restricting smoking in federal housing complex
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
In Q1, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $30,000. The report was filed on April 15, 2016.
Original Filing: 300791891.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education, graduate medical education and health information technology initiatives and Medicaid/Medicare in the appropriations bill for the Department of Health and Human Services for FY 2016.
Medicare payment cuts affecting physicians due to Sequestration.
FDA appropriations as included in the Agriculture Appropriations bill for FY 2017
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education.
Support to repeal IPAB.
Regulations implementing Affordable Care Act, HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records and ICD-10.
H.R. 2, legislation repealing and replacing the SGR formula.
Reauthorization of the Children's Health Insurance Program (CHIP).
Possible reforms to Medicare Graduate Medical Education funding.
Agencies Lobbied
U.S. Senate
Lobbying Issues
FDA Conflict of Interest issue,Compounding issue and implementation of FDA regulations and FDA issues affecting Allergists and their patients.
Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform.
Support Health Care Truth & Transparency Act.
Support authorization of Children Hospital Graduate Medical Education program.
Issues of network adequacy in Qualified Health Plans and its impact on patients with chronic diseases.
Support reauthorization of the Children's Health Insurance Program (CHIP).
ACA implementation in general and its impact on workforce and supply.
Development of Alternative Payment Models and development of bundled payments for asthma care.
Agencies Lobbied
U.S. Senate
4th Quarter, 2015
In Q4, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $30,000. The report was filed on Jan. 27, 2016.
Original Filing: 300785473.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education, graduate medical education and health information technology initiatives and Medicaid/Medicare in the appropriations bill for the Department of Health and Human Services for FY 2016.
Medicare payment cuts affecting physicians due to Sequestration.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education.
Support to repeal IPAB.
Regulations implementing Affordable Care Act, HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records and ICD-10.
H.R. 2, legislation repealing and replacing the SGR formula.
Reauthorization of the Children's Health Insurance Program (CHIP).
Possible reforms to Medicare Graduate Medical Education funding.
Agencies Lobbied
U.S. Senate
Lobbying Issues
FDA Conflict of Interest issue,Compounding issue and implementation of FDA regulations and FDA issues affecting Allergists and their patients.
Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform.
Support Health Care Truth & Transparency Act.
Support authorization of Children Hospital Graduate Medical Education program.
Issues of network adequacy in Qualified Health Plans and its impact on patients with chronic diseases.
Support reauthorization of the Children's Health Insurance Program (CHIP).
ACA implementation in general and its impact on workforce and supply.
Development of Alternative Payment Models and development of bundled payments for asthma care.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2015
CAPITOL ASSOCIATES, INC. amended a lobbying report for representation of JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI in Q32015 on Oct. 21, 2015.
Original Filing: 300765803.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education, graduate medical education and health information technology initiatives and Medicaid/Medicare in the appropriations bill for the Department of Health and Human Services for FY 2016.
Medicare payment cuts affecting physicians due to Sequestration.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education.
Support to repeal IPAB.
Regulations implementing Affordable Care Act, HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records and ICD-10.
H.R. 2, legislation repealing and replacing the SGR formula.
Reauthorization of the Children's Health Insurance Program (CHIP).
Possible reforms to Medicare Graduate Medical Education funding.
Agencies Lobbied
U.S. Senate
Lobbying Issues
FDA Conflict of Interest issue,Compounding issue and implementation of FDA regulations and FDA issues affecting Allergists and their patients.
Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform.
Support Health Care Truth & Transparency Act.
Support authorization of Children Hospital Graduate Medical Education program.
Issues of network adequacy in Qualified Health Plans and its impact on patients with chronic diseases.
Support reauthorization of the Children's Health Insurance Program (CHIP).
ACA implementation in general and its impact on workforce and supply.
Development of Alternative Payment Models and development of bundled payments for asthma care.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2015
In Q3, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $30,000. The report was filed on Oct. 20, 2015.
Original Filing: 300762160.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education, graduate medical education and health information technology initiatives and Medicaid/Medicare in the appropriations bill for the Department of Health and Human Services for FY 2016.
Medicare payment cuts affecting physicians due to Sequestration.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education.
Legislation repealing/replacing the Sustainable Growth Rate (SGR) formula - H.R. 2
Support to repeal IPAB.
Regulations implementing Affordable Care Act, HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records and ICD-10.
Reauthorization of the Children's Health Insurance Program (CHIP)
Possible reforms to Medicare Graduate Medical Education funding.
Agencies Lobbied
U.S. Senate
Lobbying Issues
FDA Conflict of Interest issue, Compounding issue and implementation of FDA regulations and FDA issues affecting Allergists and their patients.
Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform.
Support Health Care Truth & Transparency Act.
Support authorization of Children Hospital Graduate Medical Education program.
Issues of network adequacy in Qualified Health Plans and its impact on patients with chronic diseases.
Support reauthorization of the Children's Health Insurance Program (CHIP)
ACA implementation in general and its impact on workforce and supply.
Development of Alternative Payment Models and development of bundled payments for asthma care
Agencies Lobbied
U.S. Senate
2nd Quarter, 2015
In Q2, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $30,000. The report was filed on July 17, 2015.
Original Filing: 300738208.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education, graduate medical education and health information technology initiatives and Medicaid/Medicare in the appropriations bill for the Department of Health and Human Services for FY 2016.
Medicare payment cuts affecting physicians due to Sequestration.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education.
Legislation repealing/replacing the Sustainable Growth Rate (SGR) formula - H.R. 2
Support to repeal IPAB.
Regulations implementing Affordable Care Act, HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records and ICD-10.
Reauthorization of the Children's Health Insurance Program (CHIP)
Possible reforms to Medicare Graduate Medical Education funding.
Agencies Lobbied
U.S. Senate
Lobbying Issues
FDA Conflict of Interest issue, Compounding issue and implementation of FDA regulations and FDA issues affecting Allergists and their patients.
Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform.
Support Health Care Truth & Transparency Act.
Support authorization of Children Hospital Graduate Medical Education program.
Issues of network adequacy in Qualified Health Plans and its impact on patients with chronic diseases.
Support reauthorization of the Children's Health Insurance Program (CHIP)
ACA implementation in general and its impact on workforce and supply.
Development of Alternative Payment Models and development of bundled payments for asthma care
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
In Q1, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI , earning $30,000. The report was filed on April 17, 2015.
Original Filing: 300718407.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education, graduate medical education and health information technology initiatives and Medicaid/Medicare in the appropriations bill for the Department of Health and Human Services for FY 2016.
Medicare payment cuts affecting physicians due to Sequestration.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education.
Legislation repealing/replacing the Sustainable Growth Rate (SGR) formula - H.R. 2
Support to repeal IPAB.
Regulations implementing Affordable Care Act, HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records and ICD-10.
Reauthorization of the Children's Health Insurance Program (CHIP)
Possible reforms to Medicare Graduate Medical Education funding.
Agencies Lobbied
U.S. Senate
Lobbying Issues
FDA Conflict of Interest issue, Compounding issue and implementation of FDA regulations and FDA issues affecting Allergists and their patients.
Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform.
Support Health Care Truth & Transparency Act.
Support authorization of Children Hospital Graduate Medical Education program.
Issues of network adequacy in Qualified Health Plans and its impact on patients with chronic diseases.
Support reauthorization of the Children's Health Insurance Program (CHIP)
ACA implementation in general and its impact on workforce and supply.
Agencies Lobbied
U.S. Senate
4th Quarter, 2014
In Q4, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $30,000. The report was filed on Jan. 20, 2015.
Original Filing: 300705395.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare in the appropriations bill for the Departments of Health and Human Services for FY 2015.
Medicare payment cuts affecting physicians due to Sequestration.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education. Support to repeal IPAB. Regulations implementing Affordable Care Act, HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records and ICD-10. Support HR 1331, Electronic Health Record Improvement Act.
Support HR 1331, Electronic Health Record Improvement Act. Legislation to repeal/replace the SGR formula affecting Physician fee schedule payment conversion factor. Possible reforms to Medicare Graduate Medical Education funding.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest issue, Compounding issue and implementation of FDA regulations and FDA issues affecting Allergists and their patients. Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform. Support Healthcare Truth & Transparency Act. Support authorization of Children Hospital Graduate Medical Education program.
Issues of network adequacy in Qualified Health Plans and its impact on patients with chronic diseases.
ACA implementation in general and its impact on workforce and supply
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2014
In Q3, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $30,000. The report was filed on Oct. 20, 2014.
Original Filing: 300683612.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare in the appropriations bill for the Departments of Health and Human Services for FY 2015.
Medicare payment cuts affecting physicians due to Sequestration.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education. Support to repeal IPAB. Regulations implementing Affordable Care Act, HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records and ICD-10. Support HR 1331, Electronic Health Record Improvement Act.
Support HR 1331, Electronic Health Record Improvement Act. Legislation to repeal/replace the SGR formula affecting Physician fee schedule payment conversion factor
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest issue, Compounding issue and implementation of FDA regulations and FDA issues affecting Allergists and their patients. Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform. Support Healthcare Truth & Transparency Act. Support authorization of Children Hospital Graduate Medical Education program.
Issues of network adequacy in Qualified Health Plans and its impact on patients with chronic diseases.
ACA implementation in general and its impact on workforce and supply
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2014
In Q2, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $40,000. The report was filed on July 18, 2014.
Original Filing: 300662006.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare in the appropriations bill for the Departments of Health and Human Services for FY 2015.
Medicare payment cuts affecting physicians due to Sequestration.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education. Support to repeal IPAB. Regulations implementing Affordable Care Act, HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records and ICD-10. Support HR 1331, Electronic Health Record Improvement Act.
Support HR 1331, Electronic Health Record Improvement Act. Legislation to repeal/replace the SGR formula affecting Physician fee schedule payment conversion factor
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest issue, Compounding issue and implementation of FDA regulations and FDA issues affecting Allergists and their patients. Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform. Support Healthcare Truth & Transparency Act. Support authorization of Children Hospital Graduate Medical Education program.
Issues of network adequacy in Qualified Health Plans and its impact on patients with chronic diseases.
ACA implementation in general and its impact on workforce and supply
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2014
In Q1, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $30,000. The report was filed on April 21, 2014.
Original Filing: 300645578.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare in the appropriations bill for the Departments of LHHS Education for FY 2014
Proposed cuts affecting physicians in Medicare in Sequestration.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education. Support to repeal IPAB. Regulations implementing Affordable Care Act, HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records and ICD-10. Support HR 1331, Electronic Health Record Improvement Act.
Support HR 1331, Electronic Health Record Improvement Act. Legislation to repeal/replace the SGR formula affecting Physician fee schedule payment conversion factor
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest issue, Compounding issue, (S.959) and FDA issues affecting Allergists and their patients. Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform. Support Healthcare Truth & Transparency Act. Support authorization of Children Hospital Graduate Medical Education program.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2013
In Q4, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $30,000. The report was filed on Jan. 13, 2014.
Original Filing: 300613324.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare in the appropriations bill for the Departments of LHHS Education for FY 2014
Proposed cuts affecting physicians in Medicare in Sequestration.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education. Support to repeal IPAB. Regulations implementing Affordable Care Act, HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records and ICD-10. Support HR 1331, Electronic Health Record Improvement Act.
Support HR 1331, Electronic Health Record Improvement Act. Legislation to repeal/replace the SGR formula affecting Physician fee schedule payment conversion factor
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest issue, Compounding issue, (S.959) and FDA issues affecting Allergists and their patients. Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform. Support Healthcare Truth & Transparency Act. Support authorization of Children Hospital Graduate Medical Education program.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2013
In Q3, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $30,000. The report was filed on Oct. 18, 2013.
Original Filing: 300599759.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare in the appropriations bill for the Departments of LHHS Education for FY 2014
Proposed cuts affecting physicians in Medicare in Sequestration.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education. Support to repeal IPAB. Regulations implementing Affordable Care Act, HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records and ICD-10. Support HR 1331, Electronic Health Record Improvement Act.
Support HR 1331, Electronic Health Record Improvement Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest issue, Compounding issue, (S.959) and FDA issues affecting Allergists and their patients. Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform. Support Healthcare Truth & Transparency Act. Support authorization of Children Hospital Graduate Medical Education program.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2013
In Q2, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $30,000. The report was filed on July 19, 2013.
Original Filing: 300579370.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare in the appropriations bill for the department of labor,health&human services,education for fy2014
Proposed cuts affecting physicians in Medicare in Sequestration.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education. Support to repeal IPAB. Regulations implementing Affordable Care Act, HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records and ICD-10. Support HR 1331, Electronic Health Record Improvement Act.
Support HR 1331, Electronic Health Record Improvement Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest issue, Compounding issue, (S.959) and FDA issues affecting Allergists and their patients. Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform. Support Healthcare Truth & Transparency Act. Support authorization of Children Hospital Graduate Medical Education program.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2013
In Q1, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $30,000. The report was filed on April 18, 2013.
Original Filing: 300553878.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare. H.R. 933, Continuing Appropriations.
Proposed cuts affecting physicians in Medicare in Sequestration.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education. Support to repeal IPAB. Regulations implementing Affordable Care Act, HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records and ICD-10.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest issue Compounding issue and FDA issues affecting Allergists and their patients. Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform. Support Healthcare Truth & Transparency Act. Support authorization of Children Hospital Graduate Medical Education program.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2012
In Q4, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $30,000. The report was filed on Jan. 18, 2013.
Original Filing: 300535301.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare. HJ Res 117, Continuing Appropriations through March 27, 2013.
Proposed cuts affecting physicians in Medicare in Sequestration.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education. Support S. 668 and H.R. 452 to repeal IPAB. Regulations implementing HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic recordsRegulations stemming from inactment of H.R. 4872, the Reconciliation Act of 2010. Regulations implementing Health Information Technology, meaningful use, electronic health records, medicare enrollment (PECOS), ICD-10.
Regulations stemming from HR 3590, the Patient Protection & Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest issue and FDA issues affecting Allergists and their patients. Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform. Support H.R. 451, Healthcare Truth & Transparency Act of 2011. HR 1852, S. 958 support authorization of Children Hospital Graduate Medical Education program.H.R. 6284, Breath of Fresh Air, H.R. 3627 & S. 1884, School Access to Emergency Epinephrine, H.R. 6190, Asthma Inhaler Act.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2012
In Q3, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $30,000. The report was filed on Oct. 19, 2012.
Original Filing: 300515065.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare. HJ Res 117, Continuing Appropriations through March 27, 2013.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education. Support S. 668 and H.R. 452 to repeal IPAB. Regulations implementing HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic recordsRegulations stemming from inactment of H.R. 4872, the Reconciliation Act of 2010. Regulations implementing Health Information Technology, meaningful use, electronic health records, medicare enrollment (PECOS), ICD-10.
Regulations stemming from HR 3590, the Patient Protection & Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest issue and FDA issues affecting Allergists and their patients. Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform. Support H.R. 451, Healthcare Truth & Transparency Act of 2011. HR 1852, S. 958 support authorization of Children Hospital Graduate Medical Education program.H.R. 6284, Breath of Fresh Air, H.R. 3627 & S. 1884, School Access to Emergency Epinephrine, H.R. 6190, Asthma Inhaler Act.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2012
In Q2, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $30,000. The report was filed on July 19, 2012.
Original Filing: 300492153.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education. Support S. 668 and H.R. 452 to repeal IPAB. Regulations implementing HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic recordsRegulations stemming from inactment of H.R. 4872, the Reconciliation Act of 2010. Regulations implementing Health Information Technology, meaningful use, electronic health records, medicare enrollment (PECOS), ICD-10.
Regulations stemming from HR 3590, the Patient Protection & Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest issue and FDA issues affecting Allergists and their patients. Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform. Support H.R. 451, Healthcare Truth & Transparency Act of 2011. HR 1852, S. 958 support authorization of Children Hospital Graduate Medical Education program.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2012
In Q1, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $30,000. The report was filed on April 19, 2012.
Original Filing: 300466868.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education. Support S. 668 and H.R. 452 to repeal IPAB. Regulations implementing HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic recordsRegulations stemming from inactment of H.R. 4872, the Reconciliation Act of 2010. Regulations implementing Health Information Technology, meaningful use, electronic health records, medicare enrollment (PECOS), ICD-10.
Regulations stemming from HR 3590, the Patient Protection & Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest issue and FDA issue affecting Allergists. Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform. Support H.R. 451, Healthcare Truth & Transparency Act of 2011. HR 1852, S. 958 support authorization of Children Hospital Graduate Medical Education program.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2011
In Q4, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $30,000. The report was filed on Jan. 19, 2012.
Original Filing: 300444462.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare.
H.R. 2012 and H.R. 2608, Continuing Appropriations for FY 2012.
H.R. 2608 CR for Department of Health & Human Resources FY 2012.
H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of FY 2012.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education. Support S. 668 and H.R. 452 to repeal IPAB. Regulations implementing HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records Regulations stemming from inactment of H.R. 4872, the Reconciliation Act of 2010. Regulations implementing Health Information Technology, meaningful use, electronic health records, medicare enrollment (PECOS), ICD-10.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest issue and FDA issue affecting Allergists. Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform. Support H.R. 451, Healthcare Truth & Transparency Act of 2011. HR 1852, S. 958 support authorization of Children Hospital Graduate Medical Education program.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2011
In Q3, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $20,000. The report was filed on Oct. 18, 2011.
Original Filing: 300418065.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare.
H.R. 3070 and S.1599 Appropriations for the Department of Health & Human Services FY 2011, FY 2012. H.R. 2012 and H.R. 2608, Continuing Appropriations for FY 2012.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education. Support S. 668 and H.R. 452 to repeal IPAB. Regulations implementing HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records Regulations stemming from inactment of H.R. 4872, the Reconciliation Act of 2010. Regulations implementing Health Information Technology, meaningful use, electronic health records, medicare enrollment (PECOS), ICD-10.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest issue and FDA issue affecting Allergists. Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform. Support H.R. 451, Healthcare Truth & Transparency Act of 2011. HR 1852, S. 958 support authorization of Children Hospital Graduate Medical Education program.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2011
In Q2, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $20,000. The report was filed on July 19, 2011.
Original Filing: 300396145.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare. Appropriations for the Department of Health & Human Services FY 2011, FY 2012.
HR 1, Full year continuing appropriations for 2011 Presidents FY 2012 Budget.
HR 3082, Continuing Resolution through March 4, 2011.
H.J. Res 44 & 48 - continuing resolution amendments FY 2011.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation to fix or affecting the Medicare Physician Fee problem and Graduate Medical Education. Support S. 668 and H.R. 452 to repeal IPAB. Regulations implementing HIT, ACO's, Physician Fee Schedule, Medicare fraud and abuse, electronic records Regulations stemming from inactment of H.R. 4872, the Reconciliation Act of 2010. Regulations implementing Health Information Technology, meaningful use, electronic health records, medicare enrollment (PECOS), ICD-10.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest issue and FDA issue affecting Allergists. Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform. Support H.R. 451, Healthcare Truth & Transparency Act of 2011. HR 1852, S. 958 support authorization of Children Hospital Graduate Medical Education program.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2011
In Q1, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $20,000. The report was filed on April 19, 2011.
Original Filing: 300370913.xml
Lobbying Issues
Funding for asthma and allergy programs, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare. Appropriations for the Department of Health & Human Services FY 2011, FY 2012.
HR 1, Full year continuing appropriations for 2011 Presidents FY 2012 Budget.
HR 3082, Continuing Resolution through March 4, 2011.
H.J. Res 44 & 48 - continuing resolution amendments FY 2011.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation to fix the the Medicare Physician Fee problem. Support S. 668 and H.R. 452 to repeal IPAB. Regulations implementing HIT, ACO's Regulations stemming from inactment of H.R. 4872, the Reconciliation Act of 2010. Regulations implementing Health Information Technology, meaningful use, electronic health records, medicare enrollment (PECOS), ICD-10.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest issue and FDA issue affecting Allergists. Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform. Support H.R. 451, Healthcare Truth & Transparency Act of 2011.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2010
In Q4, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $20,000. The report was filed on Jan. 19, 2011.
Original Filing: 300344876.xml
Lobbying Issues
Funding for biomedical research for asthma and allergies, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare. Appropriations for the Department of Health & Human Services FY 2011
HR 3082, Continuing Resolution through March 4, 2011.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 4994, Medicare & Medicaid Extenders Act, creating one year delay for implementing SGR cuts.Regulations stemming from the H.R. 3590, Patient Protection and Affordable Care Act - Health Care Reform and impact on physicians payment and physican workforce issues and regulations implementing law. Regulations stemming from inactment of H.R. 4872, the Reconciliation Act of 2010. Regulations implementing Health Information Technology, meaningful use, electronic health records, medicare enrollment (PECOS), ICD-10.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest issue and FDA issue affecting Allergists. Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform.HR 1378 and S. 456, to direct Secretary of HHS in consultation with Secretary of Education to develop guidelines to be used on a voluntary bases to develop plans to manage the risk of food allergy and anaphylaxis in schools and early childhood programs, to establish school based food allergy management grants and other purposes.
HR 2260 and S. 1577, the Asthma Act, support efforts to alleviate asthma in U.S.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2010
In Q3, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $20,000. The report was filed on Oct. 19, 2010.
Original Filing: 300320713.xml
Lobbying Issues
Funding for biomedical research for asthma and allergies, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare. Appropriations for the Department of Health & Human Services FY 2011
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 4851, The Continuing Extension Act of 2010 - Support delay of 21% cut in Medicare Reimbursement thru 5/31 (Public Law 111-157).
H.R. 4213, Short term Extension - support delay of Medicare Physician Pay cut until September 30th.Regulations stemming from the H.R. 3590, Patient Protection and Affordable Care Act - Health Care Reform and impact on physicians payment and physican workforce issues and regulations implementing law. Regulations stemming from inactment of H.R. 4872, the Reconciliation Act of 2010. Regulations implementing Health Information Technology, meaningful use, electronic health records, medicare enrollment (PECOS), ICD-10.
H.R. 3961 Medicare Physician Payment Reform Act of 2009, SGR Fix and block cut in Medicare Physician Fee and regulations affecting physician pay.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest issue and FDA issue affecting Allergists. Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform.HR 1378 and S. 456, to direct Secretary of HHS in consultation with Secretary of Education to develop guidelines to be used on a voluntary bases to develop plans to manage the risk of food allergy and anaphylaxis in schools and early childhood programs, to establish school based food allergy management grants and other purposes.
HR 2260 and S. 1577, the Asthma Act, support efforts to alleviate asthma in U.S.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2010
In Q2, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $20,000. The report was filed on July 19, 2010.
Original Filing: 300293260.xml
Lobbying Issues
Funding for biomedical research for asthma and allergies, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 4851, The Continuing Extension Act of 2010 - Support delay of 21% cut in Medicare Reimbursement thru 5/31 (Public Law 111-157).
H.R. 4213, Short term Extension - support delay of Medicare Physician Pay cut until September 30th.H.R. 3590, Patient Protection and Affordable Care Act - Health Care Reform and impact on physicians payment and physican workforce issues and regulations implementing law. Regulations stemming from inactment of H.R. 4872, the Reconciliation Act of 2010.
H.R. 3961 Medicare Physician Payment Reform Act of 2009, SGR Fix and block cut in Medicare Physician Fee.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest issue and FDA issue affecting Allergists. Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform.HR 1378 and S. 456, to direct Secretary of HHS in consultation with Secretary of Education to develop guidelines to be used on a voluntary bases to develop plans to manage the risk of food allergy and anaphylaxis in schools and early childhood programs, to establish school based food allergy management grants and other purposes.
HR 2260 and S. 1577, the Asthma Act, support efforts to alleviate asthma in U.S.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2010
In Q1, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $40,000. The report was filed on April 19, 2010.
Original Filing: 300264858.xml
Lobbying Issues
Funding for biomedical research for asthma and allergies, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
America's Healthy Future Act
HR 3200, America's Affordable Health Choices Act of 2009 and Health Care Reform, physician payment, graduate medical education, health information technology, meaningful use, pay for performance, PQRI, implementation of ICD-10, IVIG reimbursement issues.H.R. 3590, Patient Protection and Affordable Care Act - Health Care Reform and impact on physicians payment and physican workforce issues.
H.R. 4872, The Reconciliation Act of 2010 - Health Care revisions affecting Medicare Physician Payments.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest issue and FDA issue affecting Allergists. Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform.HR 1378 and S. 456, to direct Secretary of HHS in consultation with Secretary of Education to develop guidelines to be used on a voluntary bases to develop plans to manage the risk of food allergy and anaphylaxis in schools and early childhood programs, to establish school based food allergy management grants and other purposes.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2009
In Q4, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $40,000. The report was filed on Jan. 19, 2010.
Original Filing: 300239262.xml
Lobbying Issues
HR 3293, Appropriations for Labor, Health & Human Services, funding for biomedical research for asthma and allergies, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare.
HR 3288, Consolidated Appropriations Bill, funding for health programs, research, asthma, allergies, HIT, GME, Medicare and Medicaid.
HJ Res. 64, third Continuing Resolution - funding of Federal programs.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
America's Healthy Future Act
HR 3200, America's Affordable Health Choices Act of 2009 and Health Care Reform, physician payment, graduate medical education, health information technology, meaningful use, pay for performance, PQRI, implementation of ICD-10, IVIG reimbursement issues.HR 3590, Patient Protection and Affordable Care Act - Health Care Reform and impact on physicians payment and physican workforce issues.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest issue and FDA issue affecting Allergists. Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform.HR 1378 and S. 456, to direct Secretary of HHS in consultation with Secretary of Education to develop guidelines to be used on a voluntary bases to develop plans to manage the risk of food allergy and anaphylaxis in schools and early childhood programs, to establish school based food allergy management grants and other purposes.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2009
In Q3, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $20,000. The report was filed on Oct. 20, 2009.
Original Filing: 300216360.xml
Lobbying Issues
HR 3293, Appropriations for Labor, Health & Human Services, funding for biomedical research for asthma and allergies, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
America's Healthy Future Act
HR 3200, America's Affordable Health Choices Act of 2009 and Health Care Reform, physician payment, graduate medical education, health information technology, meaningful use, pay for performance, PQRI, implementation of ICD-10, IVIG reimbursement issues.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest issue and FDA issue affecting Allergists. Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2009
In Q2, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $20,000. The report was filed on July 17, 2009.
Original Filing: 300181896.xml
Lobbying Issues
Appropriations for Labor, Health & Human Services, funding for biomedical research for asthma and allergies, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health Care Reform, physician payment, graduate medical education, health information technology, meaningful use, pay for performance, PQRI, implementation of ICD-10, IVIG reimbursement issues.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest issue and FDA issue affecting Allergists. Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2009
In Q1, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $40,000. The report was filed on April 17, 2009.
Original Filing: 300152455.xml
Lobbying Issues
H.R. 1, American Recovery & Reinvestment Act of 2009 funding for biomedical research for asthma and allergies, health care quality, pediatric graduate medical education and health information technology initiatives and Medicaid/Medicare.
H. J. Res. 38, Making Continuing Appropriations for fiscal year 2009.
H.R. 1105, Making Omnibus Appropriations for the fiscal year ending September 30, 2009.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 2, Amend title XX1 of the Social Security Act to extend and improve the Children's Health Insurance Program and for other purposes--track and monitor S-CHIP Reauthorization and Medicaid Funding.Track, monitor, report on legislative issues related to Medicare including Physician Fee Schedule, Pay for Performance Graduate Medical Education, IVIG and Reimbursement, ICD 10 Code Implementation and issues important to Allergist and Immunologist. Support legislation to negate medicare physician fee cuts and provide update. Track and monitor S-CHIP reauthorization and Medicaid funding. Track and monitor Medicare and Health Care Reform.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest issue and FDA issue affecting Allergists. Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality, patient safety initiatives and health care reform.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2008
In Q4, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $40,000. The report was filed on Jan. 16, 2009.
Original Filing: 300122888.xml
Lobbying Issues
S.3230 Funding for Departments of Labor, Health & Human Services, Education and Related Agencies Fiscal Year 2009, as it relates to biomedical research for asthma and allergies, health care quality, pediatric graduate medical education and health information technology initiatives.
H.R.2638, Consolidated Security Disaster Assistance and Continuing Appropriations for DLHHS and related agencies and other agencies.
H.R. 7110, Job Creation and Unemployment Act of 2008, track funding for Medicaid and NIH.
S. 3604; S.3689, Economic Recovery Act of 2008, track funding Medicaid and NIH.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Track, monitor, report on legislative issues related to Medicare including Physician Fee Schedule, Pay for Performance Graduate Medical Education, IVIG and Reimbursement issues important to Allergist and Immunologist. Support legislation to negate medicare physician fee cuts and provide update. Track and monitor S-CHIP reauthorization and Medicaid funding.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest issue and FDA issue affecting Allergists. Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality and patient safety initiatives. Support enactment of HR 2063, Food Allergy & Anaphylaxis Management Act of 2008.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2008
In Q3, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $20,000. The report was filed on Oct. 16, 2008.
Original Filing: 300095324.xml
Lobbying Issues
S.3230 Funding for Departments of Labor, Health & Human Services, Education and Related Agencies Fiscal Year 2009, as it relates to biomedical research for asthma and allergies, health care quality, pediatric graduate medical education and health information technology initiatives.
H.R.2638, Consolidated Security Disaster Assistance and Continuing Appropriations for DLHHS and related agencies and other agencies.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Track, monitor, report on legislative issues related to Medicare including Physician Fee Schedule, Pay for Performance Graduate Medical Education, IVIG and Reimbursement issues important to Allergist and Immunologist. Support legislation to negate medicare physician fee cuts and provide update. Track and monitor S-CHIP reauthorization and Medicaid funding.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest issue and FDA issue affecting Allergists. Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality and patient safety initiatives. Support enactment of HR 2063, Food Allergy & Anaphylaxis Management Act of 2008.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2008
In Q2, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $20,000. The report was filed on July 18, 2008.
Original Filing: 300071429.xml
Lobbying Issues
Funding for Departments of Labor, Health & Human Services, Education and Related Agencies Fiscal Year 2009, as it relates to biomedical research for asthma and allergies, health care quality, pediatric graduate medical education and health information technology initiatives.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Track, monitor, report on legislative issues related to Medicare including Physician Fee Schedule, Pay for Performance Graduate Medical Education, IVIG and Reimbursement issues important to Allergist and Immunologist. Support legislation to negate medicare physician fee cuts and provide update. Track and monitor S-CHIP reauthorization and Medicaid funding.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest issue and FDA issue affecting Allergists. Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality and patient safety initiatives. Support enactment of HR 2063, Food Allergy & Anaphylaxis Management Act of 2008.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2008
In Q1, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $20,000. The report was filed on April 17, 2008.
Original Filing: 300040998.xml
Lobbying Issues
Funding for Departments of Labor, Health & Human Services, Education and Related Agencies Fiscal Year 2009, as it relates to biomedical research for asthma and allergies, health care quality, pediatric graduate medical education and health information technology initiatives.
H. Con. Res 312/ S. Con Res 70, Budget Resolution for FY 2009.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Track, monitor, report on legislative issues related to Medicare including Physician Fee Schedule, Pay for Performance Graduate Medical Education and Reimburstment issues important to Allergist and Immunologist.
Track and monitor S-CHIP reauthorization and Medicaid funding.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA Conflict of Interest Issues and FDA issues affecting Allergists.
Monitor and track: Health Information Techonolgy issues; Asthma & Allergy Legislation, Clinical Research, healthcare quality and patient safety initiatives.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 5, S.997 Stem Cell Research Enhancement Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
0th Quarter, 2007
In MM, CAPITOL ASSOCIATES, INC. lobbied for JOINT COUNCIL OF ALLERGY, ASTHMA AND IMMUNOLOGY , earning $40,000. The report was filed on Aug. 7, 2007.
Original Filing: 200047835.xml
Lobbying Issues
S.1710, Making appropriations for the Departments of Labor, Health and Human Services and Education and related agencies for fiscal year ending September 30, 2008.
H.J. Res 20 & H.J. Res, 102, Making further appropriations for Fiscal Year 2007 and other purposes.
Agencies Lobbied
Y
Y
Department of Health and Human Services
Lobbying Issues
Track, monitor, report on legislative issues related to Medicare including Physician Fee Schedule, Pay for Performance Graduate Medical Education and Reimbursement issues important to Allergist and Immunologists.
Track and monitor S-CHIP reauthorization.
Agencies Lobbied
Y
Y
Department of Health and Human Services.
Lobbying Issues
H.R., 1561, S.1082, Food & Drug Administration Revitalization Act.
FDA Conflict of Interest Issues.
Monitor and track: Health Information Technology issues; Asthma & Allergy Legislation, Clinical Research.
Lobbying Issues
S.5, S.997 Stem Cell Research Enhancement Act.
Type of Issue
Medical/Disease Research/Clinical Labs
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...